Skip to main content

Animations

MJFF Publications

6011 - 6020 of 8824 Results
Title
Year
  • Year
  • 2015
  • 2021
  • 2021
  • 2020
  • 2019
  • 2015
  • 2013
  • 2020
  • 2020
  • 2022
  • Summary Details
    OPEN
    Title: Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-015-0010-2
    Citation Count: 145
  • Summary Details
    OPEN
    Title: Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2021.10207
    Citation Count: 154
  • Summary Details
    OPEN
    Title: Biofunctionalised bacterial cellulose scaffold supports the patterning and expansion of human embryonic stem cell-derived dopaminergic progenitor cells
    Journal Name: Stem Cell Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13287-021-02639-5
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Tossing and Turning in Bed: Nocturnal Movements in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28006
    Citation Count: 60
  • Summary Details
    OPEN
    Title: The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.027
    Citation Count: 18
  • Summary Details
    RESTRICTED
    Title: Is the MC1R variant p.R160W associated with Parkinson's?
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24527
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2013.05.017
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-020-00362-y
    Citation Count: 95
  • Summary Details
    OPEN
    Title: Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency?
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.01.017
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Neurofilament light levels predict clinical progression and death in multiple system atrophy
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awac253
    Citation Count: 70
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.